LOS ANGELES--(BUSINESS WIRE)--Symbiotics has partnered with TriLinc Advisors (“TriLinc”) as part of its impact investing strategy after an in-depth due diligence process evaluating both investment performance and impact measurement.
Impact Investing is defined as investing with the specific objective to achieve a competitive financial return as well as creating positive, measurable impact in communities across the globe.
TriLinc is an innovative impact investing fund manager with a mission to link market-rate returns, positive impact, and scalable solutions. It provides growth-stage loans and trade finance to established small and medium enterprises (“SMEs”) in developing economies where access to affordable capital is significantly limited. Borrower companies must demonstrate the ability to pay market rates, pass TriLinc’s environmental, social and governance (ESG) screens, and commit to tracking and reporting on self-identified impact metrics. Since inception, TriLinc has invested over $718 million in private debt globally and seeks to demonstrate the power of the capital markets in helping to solve some of the world’s pressing socioeconomic and environmental challenges.
Symbiotics, incorporated in 2004 in Geneva, is an investment company specialized in emerging, sustainable, and inclusive finance. Symbiotics offers market research, investment advisory, and asset management services through its Swiss operations, and advisory services through its subsidiary in the UK.
“Symbiotics is very happy to partner with TriLinc, as an innovative impact investing manager based out of the United States, having built a model to reach the missing middle in emerging and frontier markets,” said Roland Dominicé, CEO of Symbiotics. “Our shared goals and vision create a natural alignment for our investors and target markets; we look forward to continue financing their operations and sharing on this experience at SOCAP this year.”
“TriLinc is looking forward to growing our partnership with Symbiotics,” said Gloria Nelund, Chairman and CEO of TriLinc. “Our firms share the vision of helping investors engage the capital markets to make investments that both meet their financial objectives and pursue positive socioeconomic and environmental impact, to change the world for the better.”
TriLinc and Symbiotics are co-hosting a private, invitation-only breakfast at SOCAP17, a gathering of leaders focused on fostering capitalism for good. For details, please contact Amy McCance at amccance@trilincglobal.com.
About TriLinc Global, LLC
TriLinc Global, LLC (“TLG”), founded in 2008, is a leading sponsor of global impact investment funds dedicated to providing investors with access to unique and competitive yield-oriented strategies that change the world for the better. Founded on the conviction that significant private capital is needed to help solve some of the world’s most pressing issues, TriLinc’s primary goal is to deliver sophisticated, institutional quality impact investment products that will attract private capital at scale. TLG sponsored funds are managed through its two SEC Registered Investment Advisor subsidiaries, TriLinc Advisors, LLC and TriLinc Global Advisors, LLC. For more information, please visit www.trilincglobal.com.
About Symbiotics
Symbiotics is an investment company specialized in emerging, sustainable and inclusive finance. Since its inception in 2005, it has invested USD 3.8 billion in more than 360 financial institutions in 75 emerging countries, working as an advisor or manager of about 30 investment funds and many institutional investors. The firm is headquartered in Geneva, Switzerland, with offices in Cape Town, London, Zurich, Mexico City, and Singapore, employing over 120 staff globally. Symbiotics currently reaches out, indirectly through its investments, to more than 1,600,000 small enterprises and low income households at the base of the pyramid in emerging and frontier markets. For more information, please visit www.symbioticsgroup.com.
